3Chan AT, Arber N,Burn J,et al. Aspirin in the chemopre- vention of colorectal neoplasia:an overview[J].Cancer Prey Res,2012,5(2):164-178.
4ZHang X,Smith-Warner SA,Chan AT,et al. Aspirin use, body mass index,physical activity,plasma C-peptide,and colon cancer risk in US health professionals [J].Am J Epidemiol, 2011,174(4):459-467.
5Ruder EH,Laiyemo AO,Graubard BI,et al. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large ,prospective cohort [J].Am J Gastroenterol, 2011,106 (7):1340-1350.
6Burn J,Bishop DT,Chapman PD,et al. A randomized placebo-controlled prevention trial of aspirin and/or resis- tant starch in young people with familial adenomatous polyposis[J].Cancer Prey Res(Phila), 2011,4(5):655-665.
7Murff HJ,Shrubsole MJ,Chen Z,et al. Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps [J].Cancer Prey Res (Phila), 2011,4 (11) : 1799-1807.
8Zubiaurre L,Bujanda Femandez de Pierola L. Aspirin in the prevention of eoloreetal eaneer[J].Gastroenterol Hepatol, 2011,34(5):337-345.
9Giovannucci E,Chan AT. Role of vitamin and mineral supplementation and aspirin use in cancer survivors [J].J Clin Oncol, 2010,28(26):4081-4085.
10Bum J,Gerdes AM,Macrae F,et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer:an analysis from the CAPP2 randomised controlled trial[J].Lancet, 2011,378(9809):2081-2087.
